E-Paper
Dr Reddy’s Q1 profit rises by 7% to Rs 361 cr
Dr Reddy’s Laboratories (DRL) today reported a net profit rise by over 7% to Rs 361 crore for the quarter ended June 30, primarily driven by North American revenues.
Updated on: Jul 30, 2013, 21:20:10 IST
Share via
Copy link
Dr Reddy’s Laboratories (DRL) on Tuesday reported a net profit rise by over 7% to Rs 361 crore for the quarter ended June 30, primarily driven by North American revenues.
Net income from sales and services stood at Rs 2,845 crore against Rs 2,541 crore a year ago (an increase of 12%).
North American revenues from generic sales stood at Rs 1,090 crore, up 37% over last year.
Sales from India, however, remained flat at Rs 350 crore due to the implantation of new Drug Pricing Policy 2012 which led to destocking in the trade coupled with the strike by Maharashtra traders, DRL said.
Stay updated with the latest Business News, stock market updates, petrol and diesel prices, gold and silver rates, income tax updates and major developments from India and across the world.
